RB1 and nasopharyngeal carcinoma: Wu et al. [36] reported that MicroRNA-188 exerted anticancer effects in human nasopharyngeal carcinoma (NPC) via downregulation of multiple G1/S related cyclin/CDKs including CCNA2 and Rb/E2F signaling pathway.